StockData

Niki BioSolutions, Inc. (NIKI) bonds

NIKINasdaqMeasuring & Controlling Devices, NECFiscal year ends December 31
Số liệu tài chính tới Q4 năm tài chính 2025, quý kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 27, 2026Score 4/30
$1.60+0.10 (+6.67%)

Close on Nov 18, 2026Market cap $13.03MP/E –Yield –

Debt

Borrowings on the balance sheet, Dec 31, 2025

Niki BioSolutions reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

Notes and loans outstanding

As tagged in Niki BioSolutions's 20-F for the period ended Sep 11, 2023

IssueCouponAmount issued
Convertible Notes
Convertible
–$3.00M
June Two Thousand Twenty Three Notes
Convertible at $3 a share
7.00%–
Sep Two Thousand Twenty Three Notes
Convertible at $2 a share
6.00%–

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 20-F.

See a number that looks wrong?